Sean Hickey, MD
Surgical Critical Care · San Diego, CANPI 1952669699
Payments from drug & device makers
What this record shows
This record is dominated by other: $491 of the $782 with a category attached, or 62.8%. Integra Lifesciences Corporation accounts for 65.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $605 and has fallen 96.6% since, to $21 in 2025. That places this record below the midpoint for surgical critical care clinicians in CA, where the typical reported total is $1,135.
Across 13 payments — averaging $60.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$510
- Avita Medical Americas, LLC$90
- Solventum Corporation$48
- Organogenesis Inc.$35
- Lifenet Health$33
- Urgo Medical North America, LLC$26
- plus $40 from 2 others
What the payments were for
- Food & beverage$29137%
- Other$49163%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 2 | $510 |
| Avita Medical Americas, LLC | 4 | $90 |
| Solventum Corporation | 2 | $48 |
| Organogenesis Inc. | 1 | $35 |
| Lifenet Health | 1 | $33 |
| Urgo Medical North America, LLC | 1 | $26 |
| Smith+Nephew | 1 | $21 |
| KCI USA, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACell$491
How this compares
$782 in reported general payments places this provider in the 45th percentile of 141 surgical critical care providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 12 | $76 |
Paid to pharmacies, not to this prescriber.
Other surgical critical care in San Diego
- Amy LiepertSan Diego$22K
- Matthew MartinSan Diego$15K
- Jay DoucetSan Diego$12K
- Sara EdwardsSan Diego$9K
- George VentroSan Diego$2K
- Aaron StrumwasserLynwood$200K
- Demetrios DemetriadesLos Angeles$192K
- David SpainPalo Alto$117K
- Brian LugoPasadena$61K
- Matthew BloomSan Jose$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.